NovMetaPharma Co., Ltd.
- Biotech or pharma, therapeutic R&D
NovMetaPharma is focused on developing novel treatments for metabolic and fibrotic diseases and has two lead assets in the clinic; Cyclo-Z and CHP.
June 16-19, 2025
Boston Convention & Exhibition Center
NovMetaPharma is focused on developing novel treatments for metabolic and fibrotic diseases and has two lead assets in the clinic; Cyclo-Z and CHP.